|

KLN-1010 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Kelonia Therapeutics, Inc.1

Indications

  • Gene Therapy1
  • Immune System Disease1
  • Hematologic Disease and Disorders1
  • Vascular Disorder1
  • Immunoproliferative Disorders1

Other1 trial

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.